Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion

Topic: Disease mechanisms in lab and animal studies

Microglial cells and astrocytes are closely associated with nearly all compact deposits of the amyloid beta-protein found in the senile plaques characteristic of Alzheimer's disease and trisomy 21. The biosynthesis and metabolic fate of the beta-amyloid precursor protein (beta APP) in astrocytes has not been characterized, and its identification in microglia has not been described. Here, we report the expression of beta APP by astrocytes and microglia in primary cultures of cerebral cortex from newborn rats. Using metabolic labeling followed by immunoprecipitation, we show that both astrocytes and microglia express substantial amounts of the major isoforms of beta APP. This is confirmed by PCR-mediated amplification of the corresponding mRNAs, showing that all three major transcripts (beta APP695, beta APP751, and beta APP770) are present in relatively equal amounts. Despite rapid turnover of the precursor, astrocytes and microglia show a reduced production of soluble fragments of beta APP compared to cells transfected with beta APP cDNAs. The relative amount of soluble beta APP molecules generated is both cell type and isoform specific. Immunocytochemistry reveals that full-length beta APP is located in internal membranous vesicles, with only very little insertion at the cell surface. The latter data are in agreement with the reduced ability of microglia and astrocytes to cleave the beta APP into soluble derivatives. Our findings indicate that both astrocytes and microglia strongly express all three major forms of beta APP but apparently process these molecules by an alternative pathway that generates very small amounts of soluble beta APP. The immunocytochemical localization and the biochemical data lead to the suggestion that beta APP may not function principally as a cell surface or secreted protein in vivo but may have an important intracellular function.

Key findings

• Microglial cells and astrocytes are closely associated with nearly all compact deposits of the amyloid beta-protein found in the senile plaques characteristic of Alzheimer's disease and trisomy 21.
• Despite rapid turnover of the precursor, astrocytes and microglia show a reduced production of soluble fragments of beta APP compared to cells transfected with beta APP cDNAs.
• Our findings indicate that both astrocytes and microglia strongly express all three major forms of beta APP but apparently process these molecules by an alternative pathway that generates very small amounts of soluble beta APP.
• The immunocytochemical localization and the biochemical data lead to the suggestion that beta APP may not function principally as a cell surface or secreted protein in vivo but may have an important intracellular function.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1523/jneurosci.11-12-03783.1991
• PubMed: 1744690
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{haass1991-1744690,
  author  = {Haass, C. and Hung, A. Y. and Selkoe, D. J.},
  title   = {{Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion}},
  journal = {The Journal of neuroscience : the official journal of the Society for Neuroscience},
  year    = {1991},
  doi     = {10.1523/jneurosci.11-12-03783.1991},
  pmid    = {1744690},
  url     = {https://doi.org/10.1523/jneurosci.11-12-03783.1991}
}

Related studies in Down syndrome and Alzheimer's

• Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells The Journal of biological chemistry · 2009-06-19 · usefulness score 42/100
• Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease Stem cell reports · 2017-03-09 · usefulness score 42/100
• Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains Brain research · 2003-05-01 · usefulness score 45/100
• Mapping of the gene encoding the beta-amyloid precursor protein and its relationship to the Down syndrome region of chromosome 21 Proceedings of the National Academy of Sciences of the United States of America · 1988-11-01 · usefulness score 44/100
• Nerve growth factor increases mRNA levels for the prion protein and the beta-amyloid protein precursor in developing hamster brain Proceedings of the National Academy of Sciences of the United States of America · 1988-12-01 · usefulness score 43/100
• Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients Science (New York, N.Y.) · 1998-01-01 · usefulness score 41/100

Similar studies

• Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide 1993 · Tau biomarkers
• Production of the Alzheimer amyloid beta protein by normal proteolytic processing 1992 · Tau biomarkers
• Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing 1990 · Risk genes beyond APOE
• Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein 1993 · Risk genes beyond APOE
• Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons 1995 · Drug development
• Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments 1992 · Risk genes beyond APOE

More on Down syndrome and Alzheimer's

• A review that covers this ground beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease Trends in neurosciences · 1993-10-01 · usefulness score 36/100
• Newest in this subject Differential endothelial cell remodeling in Down syndrome and APP duplication drives distinct blood brain barrier dysfunction bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Memory and Plasma pTau217 Refine Prognosis in Down Syndrome Annals of neurology · 2026-10-02 · Peer-reviewed · usefulness score 47/100

See all studies in Down syndrome and Alzheimer's →